DILOR Drug Patent Profile
✉ Email this page to a colleague
When do Dilor patents expire, and when can generic versions of Dilor launch?
Dilor is a drug marketed by Savage Labs and is included in two NDAs.
The generic ingredient in DILOR is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
Summary for DILOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 3,532 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DILOR at DailyMed |
US Patents and Regulatory Information for DILOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Savage Labs | DILOR | dyphylline | TABLET;ORAL | 084514-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Savage Labs | DILOR-400 | dyphylline | TABLET;ORAL | 084751-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |